CEACAM5 and cancer: Suggested biomarkers, such as carcinoembryonic antigen (CEA) and cancer antigen 15-3 or 27-29 (CA15-3, CA27-29), usually lack sensitivity and/or specificity, and thus not suitable for early disease detection (9).